Byetta Lawsuit & Pancreatic Cancer Information
A growing number of Byetta lawsuits have been filed on behalf of individuals who allege use of the popular type 2 diabetes drug can cause pancreatitis, pancreatic cancer and thyroid cancer. Since 2008, several Byetta warnings have also been issued by the U.S. Food & Drug Administration (FDA) over similar fears. The nationwide law firm of Bernstein Liebhard LLP is currently investigating Byetta, and would like to hear from anyone who developed pancreatitis, pancreatic cancer or thyroid cancer that could be linked to their use of this medication. If you believe you or a loved one were harmed by Byetta, please contact our Firm today for your free, confidential and no-obligation Byetta lawsuit review.
Byetta was the first of a class of diabetes drugs known as incretin mimetics, which mimic the action of certain hormones found in the gastrointestinal tract. Other medications in this class include:
A self-injectable medication, Byetta works by stimulating the pancreas to produce insulin, resulting in lower blood glucose levels. Marketed by Bristol-Myers Squibb and AstraZeneca, Byetta generated more than $149 million in revenues in 2012.
Shortly after it received FDA approval in April of 2005, reports began to emerge linking Byetta and pancreatitis. By October 2007, the FDA had issued its first Byetta pancreatitis warning, after 30 Byetta users were diagnosed with an acute form of the disease. A second Byetta warning was issued by the agency in 2008, after the FDA received 6 more reports of Byetta users developing pancreatitis, including two deaths.
Byetta pancreatitis occurs when the pancreas becomes inflamed. Symptoms of the disorder may include:
- Abdominal pain that radiates into the back. This symptom can be triggered or become worse by eating, especially foods that are high in fat.
- Swelling or tenderness in the abdomen
- Nausea and vomiting
- Increased heart rate
Byetta and Pancreatic Cancer
Concerns about Byetta and pancreatic cancer began to emerge in February 2011, after a study published in Gastroenterology reported that use of Byetta increased the risk for the disease by nearly three-fold. On March 14, 2013, the FDA announced it was investigating Byetta and other incretin mimetics after findings from an unpublished study indicated the drugs could cause precancerous changes in the pancreas called pancreatic duct metaplasia.
Pancreatic cancer is the fourth leading cause of cancer death for both men and women and is one of the most deadly cancers. Because of the possible risk of Byetta pancreatic cancer, users of this drug should notify their doctors if they experience any of the following symptoms:
Byetta Thyroid Cancer
The FDA has asked the makers of Byetta and other incretin mimetics to study a possible association between the drugs and thyroid cancer. In the meantime, a 2011 study published in the journal, Gastroenterology, reported 30 cases of Byetta thyroid cancer in patients taking the drug. While the study authors said the findings did not prove a definitive link between Byetta and thyroid cancer, they did caution that people with a family history of the disease should avoid using the drug.
Individuals who take Byetta should remain vigilant for symptoms of thyroid cancer. Warning signs of Byetta thyroid cancer might include:
- A lump in the center-front of the neck.
- Hoarseness or other changes in the voice.
- Difficulty swallowing.
- Pain in the throat or neck.
- Swollen lymph nodes.
- Chronic cough
- Severely enlarged thyroid gland called a goiter.
Learn More about Filing a Byetta Lawsuit
Bernstein Liebhard LLP has recovered millions of dollars on behalf of people injured by defective drugs and medical devices. You can be assured that our Byetta lawyers will do everything possible to help you obtain the compensation needed to cover your medical bills, lost wages, pain and suffering and other damages. For more information and to arrange for a free Byetta lawsuit review, please contact us today at .